Alivus Life Sciences Limited, a active public limited company, was established on 23 June 2011 in Solapur, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: L74900PN2011PLC139963. Registered under ROC Roc Pune. it is listed on BSE: 543322 and NSE: GLS. It has an authorized capital of ₹46.00 Cr and a paid-up capital of ₹24.54 Cr.
Formerly known as Zorg Laboratories Private Limited, Glenmark Life Sciences Private Limited. It upholds a compliant status. In 2024, it reported revenue of ₹2,295.26 Cr and a net worth of ₹2,332.32 Cr. Employing 2,021 professional, Its leadership includes Yasir Yusufali Rawjee (Managing Director), Manju Agarwal (Director), Vinod Naik (Whole-Time Director). Past directors included Bhavesh Bansidhar Pujara, Yasir Yusufali Rawjee, Manju Agarwal. Its latest AGM occurred on 08 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No 170-172 Chandramouli Industrial Estate, Mohol Ba, Zarpeth, Solapur, Maharashtra, 413213.
L74900PN2011PLC139963
139963
23 June 2011
₹46.00 Cr
₹24.54 Cr
Roc Pune
Listed (BSE: 543322, NSE: GLS)
Active
Explore comprehensive insights into Alivus Life Sciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Yasir Yusufali Rawjee | Managing Director | 26 Sep 2019 | Current |
| Manju Agarwal | Director | 08 Mar 2021 | Current |
| Vinod Naik | Whole-Time Director | 21 Oct 2022 | Current |
| Kaushikbhai Nandubhai Patel | Director | 06 Mar 2024 | Current |
| Hiren Karsanbhai Patel | Director | 06 Mar 2024 | Current |
| Savan Rashmikant Godiawala | Director | 25 Apr 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Cfo(Kmp) | 22 Apr 2022 | Past |
| Pramod Abcsdd | Additional Director | 26 Sep 2019 | Past |
| Pramod Abcsdd | Additional Director | 08 Mar 2021 | Past |
| Pramod Abcsdd | Additional Director | 07 Jul 2018 | Past |
| Pramod Abcsdd | Additional Director | 28 Sep 2020 | Past |
| Pramod Abcsdd | Director | 16 Jul 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Alivus Life Sciences Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 4.8% increase. The company also saw a slight improvement in profitability, with a 0.84% increase in profit. The company's net worth moved up by a moderate rise of 9.08%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Alivus Life Sciences had a promoter holding of 82.85% and a public holding of 17.15%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Alivus Life Sciences has a workforce of 2021 employees as of Feb 28, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Alivus Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alivus Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Alivus Life Sciences Limited last Annual general meeting of members was held on 08 Sep 2025 as per latest MCA records. was documented.
Alivus Life Sciences Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was recorded as a recent event.
The activity Savan Rashmikant Godiawala was appointed as a Director was appointed as a Director on 25 Apr 2024 & has been associated with this company since 1 year 7 months . was completed.
The activity Kaushikbhai Nandubhai Patel was appointed as a Director was appointed as a Director on 06 Mar 2024 & has been associated with this company since 1 year 9 months . was completed.
Progress on Hiren Karsanbhai Patel was appointed as a Director was appointed as a Director on 06 Mar 2024 & has been associated with this company since 1 year 9 months . was documented.
Progress on Vinod Naik was appointed as a Whole-time director was appointed as a Whole-time director on 21 Oct 2022 & has been associated with this company since 3 years 2 months . was documented.
The CIN of Alivus Life Sciences Limited is L74900PN2011PLC139963.
Alivus Life Sciences Limited is headquartered at Plot No 170-172 Chandramouli Industrial Estate, Mohol Ba, Zarpeth, Solapur, Maharashtra, 413213.
Alivus Life Sciences Limited was incorporated on 23 June 2011.
The current directors of Alivus Life Sciences Limited are
The primary industry of Alivus Life Sciences Limited is Manufacturing.
Alivus Life Sciences Limited is listed. It is listed on BSE: 543322 and NSE: GLS.
The authorized capital of Alivus Life Sciences Limited is ₹46.00 Cr, and the paid-up capital is ₹24.54 Cr.
The compliance status of Alivus Life Sciences Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX